BioSciCon Companies is a woman-owned biotechnology R&D small business located in Rockville, Maryland, USA. They specialize in the development of the proprietary platform MarkPap technology, which aims to improve the accuracy and early detection of cervical cancer and precancerous conditions.
As part of a consortium with four other companies, BioSciCon works towards commercializing their products worldwide. Their biomarker-based and telemedicine-empowered platform, MarkPap, offers low-cost, simple, and accurate cervical cancer screening solutions that are accessible and infrastructure-independent.
Generated from the website